Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price, News & Analysis

Company Overview

Fresenius Medical Care AG & Co. KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines. These offerings are complemented by a range of pharmaceuticals, including anticoagulants and iron therapies, along with digital health solutions for remote patient monitoring and data management. By integrating clinical expertise with proprietary technology, Fresenius Medical Care aims to improve treatment outcomes and enhance patient quality of life.

Founded in 1996 as a spin‐off from the Fresenius SE healthcare group, Fresenius Medical Care is headquartered in Bad Homburg, Germany. The company maintains a presence in over 50 countries across North America, Europe, Latin America and the Asia Pacific region. Its global reach is supported by manufacturing facilities, research centers and a network of more than 4,000 dialysis clinics, serving hundreds of thousands of patients worldwide.

Key Stats

• Today's Range: $24.30 to $24.51
• 50-Day Range: $23.49 to $28.79
• 52-Week Range: $18.94 to $30.46
• Volume: 229,897 shs
• Average Volume: 356,195 shs
• Market Capitalization: $14.29 billion
• P/E Ratio: 19.96
• Dividend Yield: 2.34%
• Price Target: $27.80
• Consensus Rating: Reduce

Fresenius Medical Care AG & Co. KGaA Stock Analysis - MarketRank™

Fresenius Medical Care AG & Co. KGaA scored higher than 82% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.9 / 5
• Analyst Rating: Reduce

Consensus Rating

Fresenius Medical Care AG & Co. KGaA has received a consensus rating of Reduce. The company's average rating score is 1.83, and is based on 1 buy rating, 3 hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

Fresenius Medical Care AG & Co. KGaA has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 5.0 / 5
• Proj. Earnings Growth: 27.15%

Earnings Growth

Earnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 27.15% in the coming year, from $1.51 to $1.92 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 19.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 269.60.

Price to Earnings Ratio vs. Sector

The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 19.96, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 82.44.

Price to Earnings Growth Ratio

Fresenius Medical Care AG & Co. KGaA has a PEG Ratio of 0.60. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Fresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.84. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.26% of the outstanding shares of Fresenius Medical Care AG & Co. KGaA have been sold short.

Short Interest Ratio / Days to Cover

Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 4.5.

Change versus previous month

Short interest in Fresenius Medical Care AG & Co. KGaA has recently decreased by 17.49%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Fresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 2.22%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Fresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 46.72%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 29.69% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.26% of the outstanding shares of Fresenius Medical Care AG & Co. KGaA have been sold short.

Short Interest Ratio / Days to Cover

Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 4.5.

Change versus previous month

Short interest in Fresenius Medical Care AG & Co. KGaA has recently decreased by 17.49%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.90

News Sentiment

Fresenius Medical Care AG & Co. KGaA has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Fresenius Medical Care AG & Co. KGaA this week, compared to 3 articles on an average week.

Search Interest

3 people have searched for FMS on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Fresenius Medical Care AG & Co. KGaA insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 8.37% of the stock of Fresenius Medical Care AG & Co. KGaA is held by institutions.

FMS Stock Analysis - Frequently Asked Questions

How have FMS shares performed this year?

Fresenius Medical Care AG & Co. KGaA's stock was trading at $22.64 on January 1st, 2025. Since then, FMS stock has increased by 7.6% and is now trading at $24.3550.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) released its earnings results on Tuesday, August, 5th. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.02. The firm had revenue of $5.54 billion for the quarter, compared to analysts' expectations of $5 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 3.39% and a trailing twelve-month return on equity of 6.75%.
Read the conference call transcript.

Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?

Fresenius Medical Care AG & Co. KGaA subsidiaries include NxStage Medical.

Who are Fresenius Medical Care AG & Co. KGaA's major shareholders?

Top institutional investors of Fresenius Medical Care AG & Co. KGaA include Pzena Investment Management LLC (2.50%), Dodge & Cox (0.65%), Hennessy Advisors Inc. (0.07%) and Envestnet Asset Management Inc..

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care AG & Co. KGaA investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Energy Transfer (ET), AbbVie (ABBV), GE Aerospace (GE) and Adobe (ADBE).

Company Calendar

• Record date for 6/6 Dividend: 5/23/2025
• Ex-Dividend for 6/6 Dividend: 5/23/2025
• Dividend Payable: 6/06/2025
• Last Earnings: 8/05/2025
• Today: 9/03/2025
• Next Earnings (Estimated): 11/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Healthcare
• Current Symbol: NYSE:FMS
• CIK: 1333141
• Web: www.freseniusmedicalcare.com
• Phone: (496) 172-6090
• Fax: 49-6172-609-2301
• Employees: 123,200
• Year Founded: 1912

Price Target and Rating

• Average Price Target for Fresenius Medical Care AG & Co. KGaA: $27.80
• High Price Target: $30.00
• Low Price Target: $25.60
• Potential Upside/Downside: +14.1%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.83
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.22
• Trailing P/E Ratio: 19.96
• Forward P/E Ratio: 16.13
• P/E Growth: 0.6
• Net Income: $582.08 million
• Net Margins: 3.39%
• Pretax Margin: 5.98%
• Return on Equity: 6.75%
• Return on Assets: 3.13%

Debt

• Debt-to-Equity Ratio: 0.44
• Current Ratio: 1.44
• Quick Ratio: 1.08

Sales & Book Value

• Annual Sales: $19.52 billion
• Price / Sales: 0.73
• Cash Flow: $4.61 per share
• Price / Cash Flow: 5.28
• Book Value: $29.08 per share
• Price / Book: 0.84

Miscellaneous

• Outstanding Shares: 586,830,000
• Free Float: N/A
• Market Cap: $14.29 billion
• Optionable: Optionable
• Beta: 0.90